Cystic Fibrosis / Bronchiectasis
- A Prospective, 5-Year Registry Study to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa (PA) Isolates from Patients with CF in the US (AIR-CF5).
PI: Emily DiMango, MD
Contact: Surinder Narula (212) 305-0251
- MPEX-207: A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MP-376 (Levofloxacin Inhalation Solution; Aeroquin ™) in Stable Cystic Fibrosis Patients.
Inhaled levofloxacin study for cystic fibrosis patients with growth of Pseudomonas in the sputum.
PI: Claire Keating, MD
Contact: Victoria Robinson RN (212) 305-0686
- MPEX-209: A Phase 3, Open-Label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquin ™) versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis Patients.
Inhaled levofloxacin vs TOBI study for cystic fibrosis patients with growth of Pseudomonas in the sputum.
PI: Claire Keating, MD
Contact: Victoria Robinson RN 212-305-0686
- A Phase 3, Randomized, Double-Blind, Placebo- Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis who Have the R117H-CFTR Mutation.
Study of the effect of Ivacaftor (Kalydeco) in patients with cystic fibrosis and the R117H mutation.
PI: Emily DiMango, MD
Contact: Emily DiMango, MD (212) 305-0290
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Repeated Courses of Aztreonam for Inhalation Solution in Subjects with Bronchiectasis and Gram-Negative Endobronchial Infection (AIR-BX2).
The study is designed to assess the safety and efficacy of Aztreonam 75mg powder and solvent for nebuliser solution (AZLI) (inhalation solution) I subjects with bronchiectasis and gram-negative infection. Two 28-day placebo-controlled treatment courses are planned, followed by one 28-day open-label course of AZLI treatment.
PI: Angela DiMango, MD
Contact: Pat Jellen (212) 305-1158
- Management of Air Contamination in CF Clinics
PI: Lisa Saiman, MD
Contact: Juyan Zhou (212) 305-9446
622 West 168 Street | PH 8 East, Room 101
